Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

The stock's fall snapped a four-day winning streak.

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

We continued to make progress on our 2022 to 2024 BOLD+1 Strategic Plan which we recently ... Chairman of the Board and Chief Executive Officer of Henry Schein (HSIC). “We have confidence ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today repor ...

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Revenue: US$12.7b (up 2.7% from FY 2023). Net income: US$390.0m (down 6.2% from FY 2023). Profit margin: 3.1% (down from 3.4% ...

Henry Schein Q4 sales grew 5.8% to $3.19 billion, missing estimates. The company was restructured into three segments.

Shares of Henry Schein Inc. HSIC shed 1.04% to $77.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.71% to 6,013.13 and ...